Gene Chi Wai Man

No ORCID on file · 19 papers in corpus · active 2011-2026

Study types

  • article 9
  • other 3
  • review 3
  • book-chapter 2
  • preprint 1

Condition tags

  • endometriosis 17
  • infertility 2
  • dysmenorrhea 1
  • dyspareunia 1
article 2026
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox15020159

Endometriosis is a hormone-dependent gynecological disease manifested by cyclic pelvic pain and female infertility. Although many studies have shown that neoangiogenesis plays an essential role in the development of early endometriosis, the…

preprint 2024
·doi:10.2139/ssrn.4786240
other 2024
Genes & diseases ·doi:10.1016/j.gendis.2023.101166
article 2023
Journal of pharmaceutical analysis ·doi:10.1016/j.jpha.2023.09.005

Endometriosis is a common chronic gynecological disease with endometrial cell implantation outside the uterus. Angiogenesis is a major pathophysiology in endometriosis. Our previous studies have demonstrated that the prodrug of epigallocate…

article 2023
Methods in cell biology ·doi:10.1016/bs.mcb.2023.04.004

Endometriosis is a chronic, painful disease whose etiology remains unknown. The development of novel therapies and diagnostic tools for endometriosis has been limited due in part to challenges in studying the disease. Recently, a few report…

article 2023
International review of cell and molecular biology ·doi:10.1016/bs.ircmb.2022.11.004

Endometriosis is a common gynecological disorder defined by the presence of endometrial tissue outside the uterus. This is commonly associated with chronic pelvic pain, infertility, and dysmenorrhea, which occurs in approximately 10% of wom…

review 2023
Critical reviews in food science and nutrition ·doi:10.1080/10408398.2021.1986465

Endometriosis is a chronic disorder characterized by the presence of endometrial glands and stroma outside the uterine cavity. It affects 8%-10% of women in their reproductive years, and represents a major clinical problem with deleterious …

article 2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.1025053

(-)-Epigallocatechin-gallate octaacetate (pro-EGCG), a prodrug of epigallocatechin-gallate (EGCG), has been used for pre-clinical study for the treatment of endometriosis. A validated analytical method has been developed for the determinati…

review 2022
Nutrients ·doi:10.3390/nu14194087

Endometriosis is defined as the development of endometrial glands and stroma outside the uterine cavity. Pathophysiology of this disease includes abnormal hormone profiles, cell survival, migration, invasion, angiogenesis, oxidative stress,…

2020
BMC cancer ·doi:10.1186/s12885-020-07455-3

BackgroundPrevious studies have shown a major green tea polyphenol (-)-epigallocatechin-3-gallate ((-)-EGCG) as a powerful anti-cancer agent. However, its poor bioavailability and requirement of a high dosage to manifest activity have restr…

article 2018
European journal of immunology ·doi:10.1002/eji.201747417

Endometriosis affects women of reproductive age via unclear immunological mechanism(s). Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of myeloid cells with potent immunosuppressive and angiogenic properties. Here, we fo…

review 2018
Autoimmunity reviews ·doi:10.1016/j.autrev.2018.03.017

Endometriosis (EMS), an estrogen-dependent inflammatory disorder affects approximately 5-10% of the general female population of reproductive age and 20-90% of women with pelvic pain and infertility. Many immunological factors are known to …

article 2015
·doi:10.1016/j.fertnstert.2015.06.021
article 2013
Angiogenesis ·doi:10.1007/s10456-013-9333-1

Endometriosis is an angiogenesis-dependent disease. Many studies demonstrated inhibition of angiogenesis leads to inhibition of endometriotic growth, however underlying mechanism is still not fully understood. Our previous study suggested v…

book-chapter 2012
·doi:10.5772/28874

Endometriosis is a common gynaecological disease, defined by the presence of endometrial tissue outside the uterus, causing pain and infertility of women in reproductive age (Galle, 1989). It is estimated that it occurs in 10-15% for women …

other 2012
book-chapter 2012
·doi:10.5772/31372

Endometriosis is one of most common gynecological disorder, but poorly understood condition. As early as in 1860, von Rokitansky (Rokitansky, 1860) is the first one to describe www.intechopen.com

article 2012
Angiogenesis ·doi:10.1007/s10456-012-9299-4

Green tea epigallocatechin-3-gallate (EGCG) can inhibit angiogenesis and development of an experimental endometriosis model in mice, but it suffers from poor bioavailability. A prodrug of EGCG (pro-EGCG, EGCG octaacetate) is utilized to enh…

other 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.07.008

OBJECTIVE: To investigate the antiangiogenesis mechanism of epigallocatechin-3-gallate (EGCG) in an endometriosis model in vivo. DESIGN: Animal studies. SETTING: University laboratory. ANIMAL(S): Human endometrium from women with endomet…